61 related articles for article (PubMed ID: 1343283)
1. Effect of manidipine, a novel calcium channel blocker, on quality of life in hypertensive patients.
Ogihara T; Nakagawa M; Ishikawa H; Mikami H; Takeda K; Nonaka H; Nagano M; Sasaki S; Kagoshima T; Higashimori K
Blood Press Suppl; 1992; 3():135-9. PubMed ID: 1343283
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of the efficacy and safety of manidipine in hypertensive patients with renal disorders.
Mizuno K; Haga H; Takahashi M; Watanabe Y; Fukuchi S
Blood Press Suppl; 1992; 3():119-23. PubMed ID: 1343279
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of manidipine hydrochloride in the long-term treatment of mild-moderate hypertension. Manidipine Efficacy in Long-Term Treatment Group.
Fogari R; Zoppi A; Lusardi P; Mugellini A
Blood Press Suppl; 1996; 5():24-8. PubMed ID: 8973789
[TBL] [Abstract][Full Text] [Related]
5. [Hypotensive effectiveness of therapy combined enalapril and nitrendipine and influence on the quality of life].
Bryl W; Cymerys M; Kujawska-Luczak M; Pupek-Musialik D
Pol Merkur Lekarski; 2005 Mar; 18(105):287-90. PubMed ID: 15997634
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of manidipine on circadian blood pressure in essential hypertension.
Nakamura T; Honma H; Kohno I; Tsuruta I; Ishii H; Tamura K
Blood Press Suppl; 1992; 3():94-101. PubMed ID: 1343299
[TBL] [Abstract][Full Text] [Related]
7. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
Rodicio JL
Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
[TBL] [Abstract][Full Text] [Related]
8. Manidipine in hypertensive patients with metabolic syndrome: the MARIMBA study.
Martínez Martín FJ
Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):863-9. PubMed ID: 19589122
[TBL] [Abstract][Full Text] [Related]
9. Add-on manidipine versus amlodipine in diabetic patients with hypertension and microalbuminuria: the AMANDHA study.
Martinez-Martin FJ; Saiz-Satjes M
Expert Rev Cardiovasc Ther; 2008 Nov; 6(10):1347-55. PubMed ID: 19018688
[TBL] [Abstract][Full Text] [Related]
10. Calcium antagonists as first-line therapy in hypertension: results of the Swiss Isradipine Study. Swiss Hypertension Society.
Lüscher TF; Waeber B
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S1-3. PubMed ID: 1720476
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in normotensives compared to hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: the LOMIR-MCT-IL study.
Yodfat Y; Bar-On D; Amir M; Cristal N
J Hum Hypertens; 1996 Feb; 10(2):117-22. PubMed ID: 8867566
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of trandolapril alone or in combination with a calcium channel blocker in hypertensive patients over 60 years of age].
Gosse P; Vaur L; Dutrey-Dupagne C; Genes N; Destrée D; Elkik F
Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):517-24. PubMed ID: 8745662
[TBL] [Abstract][Full Text] [Related]
13. French large-scale study evaluating the tolerability and efficacy of lacidipine.
Tcherdakoff P
J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S27-32. PubMed ID: 8852542
[TBL] [Abstract][Full Text] [Related]
14. Does the combination of ACE inhibitor and calcium antagonist control hypertension and improve quality of life? The LOMIR-MCT-IL study experience.
Amir M; Cristal N; Bar-On D; Loidl A
Blood Press Suppl; 1994; 1():40-2. PubMed ID: 8205297
[TBL] [Abstract][Full Text] [Related]
15. Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus.
Fogari R; Derosa G; Zoppi A; Rinaldi A; Preti P; Lazzari P; Mugellini A
Hypertens Res; 2008 Jan; 31(1):43-50. PubMed ID: 18360017
[TBL] [Abstract][Full Text] [Related]
16. Swedish Isradipine Study in Hypertension: evaluation of quality of life, safety, and efficacy. SWISH Group.
Jern S; Hansson L; Scherstén B; Kullman S; Sörensen S; Dahlöf B; Eggertsen R; Sivertsson R
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S7-8. PubMed ID: 1720487
[TBL] [Abstract][Full Text] [Related]
17. A study of the effects of manidipine on the diurnal variation of arterial pressure and hemodynamics in patients with essential hypertension.
Iwata A; Tochikubo O; Kawano Y; Minamisawa K; Miyakawa Y; Ishii M
Blood Press Suppl; 1992; 3():87-93. PubMed ID: 1343298
[TBL] [Abstract][Full Text] [Related]
18. Effect of a new calcium antagonist on hemodynamics at rest and exercise loading in patients with essential hypertension.
Suzuki S; Hashimoto T; Kusano S; Kapuku K; Utsunomiya T; Yano K
Arzneimittelforschung; 1993 Nov; 43(11):1152-6. PubMed ID: 8292057
[TBL] [Abstract][Full Text] [Related]
19. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
